BIOMAT Database Logo BIOMAT Database Logo

New approaches to the evaluation of anti-rheumatic drugs. 1974

Amor, and Brouihlet, and Delbarre, and Giroud, and Kahan, and Di Rosa, and Velo, and Turk, and Willoughby, and Timist, and P Franchimont, and Balme, and Berry, and Glynn, and Huskisson

UI MeSH Term Description Entries
D012107 Research Design A plan for collecting and utilizing data so that desired information can be obtained with sufficient precision or so that an hypothesis can be tested properly. Experimental Design,Data Adjustment,Data Reporting,Design, Experimental,Designs, Experimental,Error Sources,Experimental Designs,Matched Groups,Methodology, Research,Problem Formulation,Research Methodology,Research Proposal,Research Strategy,Research Technics,Research Techniques,Scoring Methods,Adjustment, Data,Adjustments, Data,Data Adjustments,Design, Research,Designs, Research,Error Source,Formulation, Problem,Formulations, Problem,Group, Matched,Groups, Matched,Matched Group,Method, Scoring,Methods, Scoring,Problem Formulations,Proposal, Research,Proposals, Research,Reporting, Data,Research Designs,Research Proposals,Research Strategies,Research Technic,Research Technique,Scoring Method,Source, Error,Sources, Error,Strategies, Research,Strategy, Research,Technic, Research,Technics, Research,Technique, Research,Techniques, Research
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D012216 Rheumatic Diseases Disorders of connective tissue, especially the joints and related structures, characterized by inflammation, degeneration, or metabolic derangement. Rheumatism,Disease, Rheumatic,Diseases, Rheumatic,Rheumatic Disease

Related Publications

Amor, and Brouihlet, and Delbarre, and Giroud, and Kahan, and Di Rosa, and Velo, and Turk, and Willoughby, and Timist, and P Franchimont, and Balme, and Berry, and Glynn, and Huskisson
New approaches to anti-rheumatic drugs.
February 1976, Agents and actions,
Amor, and Brouihlet, and Delbarre, and Giroud, and Kahan, and Di Rosa, and Velo, and Turk, and Willoughby, and Timist, and P Franchimont, and Balme, and Berry, and Glynn, and Huskisson
[New therapeutic approaches. 2. New anti-rheumatic drugs: with special reference to methotrexate].
October 2000, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Amor, and Brouihlet, and Delbarre, and Giroud, and Kahan, and Di Rosa, and Velo, and Turk, and Willoughby, and Timist, and P Franchimont, and Balme, and Berry, and Glynn, and Huskisson
Guidelines on new anti-rheumatic drugs.
February 1986, Annals of internal medicine,
Amor, and Brouihlet, and Delbarre, and Giroud, and Kahan, and Di Rosa, and Velo, and Turk, and Willoughby, and Timist, and P Franchimont, and Balme, and Berry, and Glynn, and Huskisson
Clinical evaluation of novel anti-rheumatic drugs.
January 1977, Agents and actions. Supplements,
Amor, and Brouihlet, and Delbarre, and Giroud, and Kahan, and Di Rosa, and Velo, and Turk, and Willoughby, and Timist, and P Franchimont, and Balme, and Berry, and Glynn, and Huskisson
[Anti-rheumatic drugs].
August 2012, Nihon rinsho. Japanese journal of clinical medicine,
Amor, and Brouihlet, and Delbarre, and Giroud, and Kahan, and Di Rosa, and Velo, and Turk, and Willoughby, and Timist, and P Franchimont, and Balme, and Berry, and Glynn, and Huskisson
Anti-rheumatic drugs.
January 1981, Pharmacology & therapeutics,
Amor, and Brouihlet, and Delbarre, and Giroud, and Kahan, and Di Rosa, and Velo, and Turk, and Willoughby, and Timist, and P Franchimont, and Balme, and Berry, and Glynn, and Huskisson
Anti-rheumatic drugs.
August 1988, Bailliere's clinical rheumatology,
Amor, and Brouihlet, and Delbarre, and Giroud, and Kahan, and Di Rosa, and Velo, and Turk, and Willoughby, and Timist, and P Franchimont, and Balme, and Berry, and Glynn, and Huskisson
Anti-rheumatic drugs: present deadlock and new vistas.
January 1980, Progress in medicinal chemistry,
Amor, and Brouihlet, and Delbarre, and Giroud, and Kahan, and Di Rosa, and Velo, and Turk, and Willoughby, and Timist, and P Franchimont, and Balme, and Berry, and Glynn, and Huskisson
[Clinical evaluation of anti-rheumatic drugs: experimentation by ordeal?].
January 1974, Reumatismo,
Amor, and Brouihlet, and Delbarre, and Giroud, and Kahan, and Di Rosa, and Velo, and Turk, and Willoughby, and Timist, and P Franchimont, and Balme, and Berry, and Glynn, and Huskisson
Newer anti-rheumatic drugs.
July 1978, Annals of internal medicine,
Copied contents to your clipboard!